What is the equity of Nov this year?
Nov has equity of 6.38 B USD this year.
Nov Equity 2025
Nov Equity
6.38 B USD
Ticker
NOV
ISIN
US62955J1034
WKN
A2QLRE
In 2025, Nov's equity was 6.38 B USD, a 3.37% increase from the 6.17 B USD equity in the previous year.
Nov Aktienanalyse
What does Nov do?
Nov Inc is a globally operating company that was founded in the USA in 1976. The company specializes in the development and manufacture of products in various fields, including pharmaceuticals, biotechnology, agrochemicals, and electronics. Nov Inc's business model is based on the research and development of new technologies and products. The company invests a significant portion of its resources in the research and development of new drugs and technologies. Nov Inc works closely with scientific organizations and universities to achieve this. The goal of Nov Inc is to develop products that have a positive impact on health, science, and the environment. The company aims to improve the quality of life for people worldwide by developing innovative products that meet the needs of its customers. Nov Inc is divided into several divisions. The main divisions are pharmaceuticals, biotechnology, diagnostics, crop protection, and electronics. In each of these divisions, the company produces products tailored to the needs of its customers. In the pharmaceutical field, Nov Inc develops and produces drugs for the treatment of various diseases such as cancer, diabetes, and cardiovascular diseases. Nov Inc's products are well-known worldwide and are taken by millions of patients every day. The company is proud to make a significant contribution to improving the health of people worldwide. In the biotechnology division, Nov Inc develops products for use in agriculture and environmental protection. This includes improved seed varieties that are more resistant to insects and diseases, thus reducing the use of pesticides. Nov Inc also produces biological pesticides that protect plants from pests while being non-toxic and environmentally friendly. In the diagnostics division, Nov Inc develops and produces tests for the diagnosis of infectious diseases and other medical conditions. These tests are important for the timely detection of diseases and enable early treatment. In the electronics division, Nov Inc develops and produces electronic devices and components. This includes semiconductors, sensors, and displays. These components are used in various industries, including telecommunications, automotive, and aerospace. In addition to the above-mentioned divisions, Nov Inc also offers other products, including food additives, colorants, fragrances, and chemicals for industrial use. Overall, Nov Inc has made a significant contribution to improving health, science, and the environment over the past decades. The company is globally recognized for its innovative products and technologies and will remain an important player in research and development in the future. Nov ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Nov's Equity
Nov's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Nov's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Nov's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Nov's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Nov’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Nov stock
What was the equity of Nov compared to the previous year?
The equity of Nov has increased/decreased by 3.37% increased compared to the previous year.
What impact does a high equity have on investors of Nov?
A high equity is advantageous for investors of Nov as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Nov?
A low equity can be a risk for investors of Nov, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Nov affect the company?
An increase in equity of Nov can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Nov affect the company?
A reduction in equity of Nov can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Nov?
Some factors that can affect the equity of Nov include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Nov so important for investors?
The equity of Nov is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Nov take to change the equity?
To change equity, Nov can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Nov pay?
Over the past 12 months, Nov paid a dividend of 0.28 USD . This corresponds to a dividend yield of about 2.18 %. For the coming 12 months, Nov is expected to pay a dividend of 0.42 USD.
What is the dividend yield of Nov?
The current dividend yield of Nov is 2.18 %.
When does Nov pay dividends?
Nov pays a quarterly dividend. This is distributed in the months of April, July, July, October.
How secure is the dividend of Nov?
Nov paid dividends every year for the past 22 years.
What is the dividend of Nov?
For the upcoming 12 months, dividends amounting to 0.42 USD are expected. This corresponds to a dividend yield of 3.34 %.
In which sector is Nov located?
Nov is assigned to the 'Energy' sector.
Wann musste ich die Aktien von Nov kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Nov from 9/26/2025 amounting to 0.075 USD, you needed to have the stock in your portfolio before the ex-date on 9/12/2025.
When did Nov pay the last dividend?
The last dividend was paid out on 9/26/2025.
What was the dividend of Nov in the year 2024?
In the year 2024, Nov distributed 0.2 USD as dividends.
In which currency does Nov pay out the dividend?
The dividends of Nov are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Nov
Our stock analysis for Nov Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nov Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
